sameAs
Taxane associated subacute cutaneous lupus erythematosus.Nitrendipine-induced subacute cutaneous lupus erythematosus.Prevalence of anticardiolipin antibodies in subacute cutaneous lupus erythematosus.ITP as an initial manifestation of subacute cutaneous lupus erythematosus.Clinical, histological and immunopathological features of 58 patients with subacute cutaneous lupus erythematosus. A review by the Italian group of immunodermatology.Long-term cefuroxime axetil in subacute cutaneous lupus erythematosus. A report of three cases.Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden.Subacute cutaneous lupus erythematosus: report of a patient who subsequently developed a meningioma and whose skin lesions were treated with isotretinoin.Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: a report of 5 cases.Subacute cutaneous lupus erythematosus associated with hepatocellular carcinoma.Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset.Association of inclusion body myositis with subacute cutaneous lupus erythematosus.Drug-induced subacute cutaneous lupus erythematosus associated with docetaxel chemotherapy: a case reportProton pump inhibitor-induced subacute cutaneous lupus erythematosusPattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice.Subacute cutaneous lupus erythematosus associated with cinnarizine and thiethylperazine therapy.Subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis.Patient with terbinafine-induced subacute cutaneous lupus erythematosus followed by thalidomide-induced orofacial neuropathy; Beta blocker use, hypertension, and the risk of psoriasis; eczematous reaction to intravenous immunoglobulin; nicolau syndrClinical relevance of antibodies to Ro/SS-A and La/SS-B in subacute cutaneous lupus erythematosus and related conditions.Tumour necrosis factor alpha is expressed in refractory skin lesions from patients with subacute cutaneous lupus erythematosusBullous subacute cutaneous lupus erythematosus.Lupus erythematosus induced by medications, ultraviolet radiation, and other exogenous agents: a review, with special focus on the development of subacute cutaneous lupus erythematosus in a genetically predisposed individual.The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score.Perturbation of experimental ultraviolet light-induced erythema by passive transfer of serum from subacute cutaneous lupus erythematosus patients.Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings.Subacute cutaneous lupus erythematosus: a paraneoplastic dermatosis?Clinical manifestations and laboratory data of subacute cutaneous lupus erythematosus.Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE).Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Proton Pump Inhibitors.Human histocompatibility antigen associations in subacute cutaneous lupus erythematosus.A case of subacute cutaneous lupus erythematosus in a patient with mixed connective tissue disease: successful treatment with plasmapheresis and rituximab.Subacute cutaneous lupus erythematosus triggered by radiotherapy.Pathogenesis of subacute cutaneous lupus erythematosus.Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature.Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation.Incidental cases of subacute cutaneous lupus erythematosus in association with malignancy.Terbinafine-induced subacute cutaneous lupus erythematosus in two patients with systemic lupus erythematosus successfully treated with topical corticosteroids.Rare Occurrence of Drug Induced Subacute Cutaneous Lupus Erythematosus with Leflunomide Therapy.Subacute cutaneous lupus erythematosus--the annular variant. A histological and ultrastructural study of five cases.A case of subacute cutaneous lupus erythematosus as a result of ranibizumab (Lucentis) treatment
P921
Q30456958-B3727A0E-18CF-473F-843D-983FC13B8D40Q33347484-B3410B0B-39FE-42E3-A4B7-9BA4AC4EAFF4Q33350168-8449445C-4FA9-4033-962B-FEC67F5BC2F3Q33369630-28588EE6-97ED-40E8-B042-29973CFFC076Q33841926-46F2351A-63CE-4549-8FF7-37EC5CB5A8A9Q33898880-5CF8CA58-EF3E-4724-B590-B73F3101FBF6Q34031291-E8DFC3E4-8DF0-411D-9618-F1B0B243F0A2Q34046514-A369D676-568F-4A9B-8C40-CD8464F97BDDQ34091421-36B32A98-E6B9-46A1-ABE4-E131A1FE75D0Q34222670-671FEA75-A63F-43BF-85C3-E0956B0BE26CQ34231522-AA18291B-C350-4FC1-9F66-40F61F652F0AQ34456455-5B78085C-F151-4B57-965C-617266CDB4ADQ34514879-AD85E2CF-948B-4F70-9634-8DA3CD74543CQ34516486-38E86462-8A28-4714-9DB8-0640A6BDCA11Q34572296-A5078009-AC4A-4340-B9AF-993FB71A2B01Q34750298-5495A176-00DB-4A54-9433-916DEF8589C4Q35030592-CCF2DFA6-560B-48E7-B487-01E18D4BABFDQ35063093-EFEFD193-A8CE-466F-8572-BD8F200556D4Q35222536-05844C7A-9A05-466F-830E-91BD5DFE50B6Q35636994-5900C720-E2B8-4F63-B310-1331ED507D54Q35759190-FE3BE581-FCA6-4DB1-A91E-BBAE40EB3332Q35763829-8C850A96-E597-4A5B-BBF3-737D8D0E84D2Q35911498-6F45E054-5C2C-474E-92A7-6FFDE15AF103Q35977429-91BDFA0D-24AA-4C58-811C-9B542BD10618Q36180056-1B325E34-B1FD-471C-8496-CB8FD298BA11Q36273476-A492B474-130D-432A-A437-3C38564BB63BQ36446690-50ADBFBB-908B-4CCE-B359-59000CE5C049Q36932377-D5733E2A-CB53-458D-A17B-DF8A933E7BF8Q37022895-330933CE-B9C7-4192-B4C2-D5E943522CFAQ37026303-116AC27F-EA2B-456D-B4D0-7ED2A5FEA519Q37101109-EFECB1C7-FD4D-4058-8157-50AB487C0B8DQ37151317-68092AFF-E1CC-4C04-8986-22E72A2216A6Q37186829-353D4E52-CCAE-418C-A705-CFC98415084BQ37194877-BC71C993-3639-4A68-A60A-5884903DF74CQ37271738-C40F01F1-EC82-4107-AEF4-B77B82FD3C66Q37309883-98148D47-C491-4219-96C7-0AAA8A1317DCQ37327217-947CEA89-2982-4A5D-86EB-BD6879A61AEEQ37435561-48268EB4-C8E1-4695-9B9B-61DA9F38064BQ37448760-0D5B18F8-5789-4469-9F6A-B553385ED1C1Q37566589-547C74BA-93EB-4E98-A9E0-6B7B07026665
P921
description
Krankheit
@de
malattia
@it
name
Lúpus eritematoso cutâneo subagudo
@pt
Podostra postać skórna tocznia rumieniowatego
@pl
Subacute cutaneous lupus erythematosus
@en
larruazaleko lupus eritematoso akutu
@eu
lupus eritematoso cutaneo subacuto
@it
lupus érythémateux cutané subaigu
@fr
亞急性皮膚型紅斑性狼瘡
@zh
亞急性皮膚型紅斑性狼瘡
@zh-cn
亞急性皮膚型紅斑性狼瘡
@zh-hans
亞急性面板型紅斑性狼瘡
@zh-hant
type
label
Lúpus eritematoso cutâneo subagudo
@pt
Podostra postać skórna tocznia rumieniowatego
@pl
Subacute cutaneous lupus erythematosus
@en
larruazaleko lupus eritematoso akutu
@eu
lupus eritematoso cutaneo subacuto
@it
lupus érythémateux cutané subaigu
@fr
亞急性皮膚型紅斑性狼瘡
@zh
亞急性皮膚型紅斑性狼瘡
@zh-cn
亞急性皮膚型紅斑性狼瘡
@zh-hans
亞急性面板型紅斑性狼瘡
@zh-hant
altLabel
subacute cutaneous lupus erythematosus
@en
亞急性皮膚紅斑狼瘡
@zh
亞急性皮膚紅斑狼瘡
@zh-cn
亞急性皮膚紅斑狼瘡
@zh-hans
亞急性面板紅斑狼瘡
@zh-hant
prefLabel
Lúpus eritematoso cutâneo subagudo
@pt
Podostra postać skórna tocznia rumieniowatego
@pl
Subacute cutaneous lupus erythematosus
@en
larruazaleko lupus eritematoso akutu
@eu
lupus eritematoso cutaneo subacuto
@it
lupus érythémateux cutané subaigu
@fr
亞急性皮膚型紅斑性狼瘡
@zh
亞急性皮膚型紅斑性狼瘡
@zh-cn
亞急性皮膚型紅斑性狼瘡
@zh-hans
亞急性面板型紅斑性狼瘡
@zh-hant
P6366
P1550
P1748
P1995
P2888
P2892
P31
P4229
P5270
MONDO:0015573
P6366
2777761306